Age-Specific Evaluation of HPV DNA Testing versus Cytology Screening
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Age-Specific Evaluation of HPV DNA Testing versus Cytology Screening

BETHESDA, Md -- November 11, 2009 -- Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a study published online November 9 in the Journal of the National Cancer Institute. Cytology triage in HPV-positive women can improve specificity.

HPV DNA testing has shown higher sensitivity than conventional cytology screening for detecting cervical lesions, but it is uncertain whether the higher sensitivity is dependent on the age of the woman being screened.

Maarit Leinonen, MD, Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland, and colleagues compared the age-specific performance of primary HPV DNA screening with that of conventional cytology screening.

Women aged 25 to 65 years were sent randomised invitations for HPV DNA testing with cytology triage or conventional screening.

Overall, primary HPV DNA screening with cytology triage was more sensitive than conventional screening for detecting cervical lesions.

Among women aged younger than 35 years, those who got HPV DNA screening were referred for colposcopy more often than those who got conventional screening. Among women aged 35 years or older, HPV DNA testing with cytology triage was more sensitive and more specific than conventional screening, had a higher precision rate, and was associated with fewer colposcopy referrals and follow-up tests.

“In countries like Finland that have a well-organised cervical screening program and low incidence of cervical cancer, new interventions are expected to provide only small increases in a screening program’s efficacy,” the authors wrote.

“Nevertheless, our results support the use of HPV DNA testing with cytology triage in primary cervical screening.”

SOURCE: Journal of the National Cancer Institute

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities